Sylvain garciaz

Company: Institut Paoli-Calmettes

Job title: MD PhD

Seminars:

Targeting KIF20A Kinesin: A Promising Strategy for Next-Generation ADC Payload 11:45 am

Presenting EVX-020, a first-in-class highly selective KIF20A inhibitor Sharing nonclinical efficacy data of EVX-020 in tumor models and the involvement of KIF20A in Golgi Function Analyzing the MoA of EVX-020, and its potential as a new ADC payloadRead more

day: Conference Day Two